• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Quanterix Corp (QTRX)

Common Shares
Sell: $6.76|Buy: $8.10|Change: 0.20 (-2.86%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platformsdesigned by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Address

900 Middlesex Turnpike
Building 1
Billerica
MA
USA
01821

Telephone

+1 617 301-9400

Website

https://www.quanterix.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Quanterix Corp Third Quarter Earnings Conference Call for 20262026-11-10T16:30:00
Quanterix Corp Third Quarter Earnings Results for 20262026-11-10T00:00:00
Quanterix Corp Annual General Meeting for 20262026-09-23T09:00:00
Quanterix Corp Second Quarter Earnings Conference Call for 20262026-08-07T16:30:00
Quanterix Corp Second Quarter Earnings Results for 20262026-08-07T00:00:00
Quanterix Corp First Quarter Earnings Conference Call for 20262026-05-12T16:30:00
Quanterix Corp First Quarter Earnings Results for 20262026-05-12T00:00:00
Quanterix Corp Fourth Quarter Earnings Conference Call for 20252026-03-17T16:30:00
Quanterix Corp Fourth Quarter Earnings Results for 20252026-03-17T00:00:00
Quanterix Corp Annual Report for 20252026-03-17T00:00:00

Previous key dates

NameKey Date
Quanterix Corp Third Quarter Earnings Conference Call for 20252025-11-10T16:30:00
Quanterix Corp Third Quarter Earnings Results for 20252025-11-10T00:00:00
Quanterix Corp Annual General Meeting for 20252025-09-23T09:00:00
Quanterix Corp CG 45th Annual Growth Conference2025-08-12T15:30:00
Quanterix Corp Second Quarter Earnings Conference Call for 20252025-08-07T16:30:00
Quanterix Corp Second Quarter Earnings Result for 20252025-08-07T00:00:00
Goldman Sachs Global Healthcare Conference2025-06-09T13:20:00
Quanterix Corp First Quarter Earnings Conference Call for 20252025-05-12T16:30:00
Quanterix Corp First Quarter Earnings Result for 20252025-05-12T00:00:00
Quanterix Corp Fourth Quarter Earnings Conference Call for 20242025-03-17T16:30:00
Quanterix Corp Fourth Quarter Earnings Result for 20242025-03-17T00:00:00
Quanterix Corp Annual Report for 20242025-03-17T00:00:00
J.P. Morgan Healthcare Conference2025-01-15T16:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.